Targetable Cancer-Associated Antigens for Immunotherapy in Malignant Pleural Mesothelioma (MPM) - Mesothelin, CA125 and WT-1

被引:0
|
作者
Ujiie, Hideki [1 ]
Eguchi, Takashi [1 ]
Mayor, Marissa [2 ,3 ]
Kadota, Kyuichi [4 ]
Travis, William D. [5 ]
Jones, David R. [1 ]
Sadelain, Michel [6 ]
Adusumilli, Prasad S. [2 ,3 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Surg, Thorac Serv, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Thorac Serv, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, New York, NY 10021 USA
[4] Kagawa Univ, Dept Diagnost Pathol, Takamatsu, Kagawa 760, Japan
[5] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA
[6] Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, New York, NY 10021 USA
关键词
Mesothelin; CA125; WT-1; Mesothelioma; Antigen Expression; Immunotherapy;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P3.08-038
引用
收藏
页码:S755 / S756
页数:2
相关论文
共 21 条
  • [1] Cancer antigen profiling for malignant pleural mesothelioma immunotherapy: expression and coexpression of mesothelin, cancer antigen 125, and Wilms tumor 1
    Eguchi, Takashi
    Kadota, Kyuichi
    Mayor, Marissa
    Zauderer, Marjorie G.
    Rimner, Andreas
    Rusch, Valerie W.
    Travis, William D.
    Sadelain, Michel
    Adusumilli, Prasad S.
    ONCOTARGET, 2017, 8 (44) : 77872 - 77882
  • [2] Does CA125 binding to mesothelin impact the detection of malignant mesothelioma?
    Creaney, Jenette
    Dick, Ian M.
    Dare, Hanne
    Demelker, Yvonne
    Nowak, Anna K.
    Musk, Arthur William
    Robinson, Bruce W. S.
    LUNG CANCER, 2013, 80 (01) : 39 - 44
  • [3] Combined CA125 and mesothelin levels for the diagnosis of malignant mesothelioma
    Creaney, Jenette
    van Bruggen, Ivonne
    Hof, Michelle
    Segal, Amanda
    Musk, Arthur W.
    de Klerk, Nick
    Horick, Nora
    Skates, Steven J.
    Robinson, Bruce W. S.
    CHEST, 2007, 132 (04) : 1239 - 1246
  • [4] Expression of Wilms' tumor gene (WT1) is associated with survival in malignant pleural mesothelioma
    Cedres, S.
    Montero, M. A.
    Zamora, E.
    Martinez, A.
    Martinez, P.
    Farinas, L.
    Navarro, A.
    Torrejon, D.
    Gabaldon, A.
    Ramon y Cajal, S.
    Felip, E.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2014, 16 (09) : 776 - 782
  • [5] Expression of Wilms’ tumor gene (WT1) is associated with survival in malignant pleural mesothelioma
    S. Cedrés
    M. A. Montero
    E. Zamora
    A. Martínez
    P. Martínez
    L. Fariñas
    A. Navarro
    D. Torrejon
    A. Gabaldon
    S. Ramon y Cajal
    E. Felip
    Clinical and Translational Oncology, 2014, 16 : 776 - 782
  • [6] Correlation of serum-soluble mesothelin-related protein, HMGB1 and CA125 in diffuse malignant peritoneal mesothelioma and their combined measurement for prognosis
    Wang, Lianfen
    Wang, Xuesong
    Sun, Ningning
    Chen, Baosheng
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2023, 83 (02) : 74 - 78
  • [7] Tumour-associated antigens CEA, CA125, SCC and TPS in gynaecological cancer
    Sarandakou, A
    Phocas, I
    Botsis, D
    Sikiotis, K
    Rizos, D
    Kalambokis, D
    Trakakis, E
    Chryssikopoulos, A
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 1998, 19 (01) : 73 - 77
  • [8] Serum soluble mesothelin-related protein (SMRP) and fibulin-3 levels correlate with baseline malignant pleural mesothelioma (MPM) tumor volumes but are not useful as biomarkers of response in an immunotherapy trial
    Katz, Sharyn, I
    Roshkovan, Leonid
    Berger, Ian
    Friedberg, Joseph S.
    Alley, Evan W.
    Simone, Charles B., II
    Haas, Andrew R.
    Cengel, Keith A.
    Sterman, Daniel H.
    Albelda, Steven M.
    LUNG CANCER, 2021, 154 : 5 - 12
  • [9] Comparison of Different Clones (WT49 Versus 6F-H2) of WT-1 Antibodies for Immunohistochemical Diagnosis of Malignant Pleural Mesothelioma
    Tsuta, Koji
    Kato, Yasufumi
    Tochigi, Naobumi
    Hoshino, Tatsuhiro
    Takeda, Yuji
    Hosako, Mutsumi
    Maeshima, Akiko Miyagi
    Asamura, Hisao
    Kondo, Tadashi
    Matsuno, Yoshihiro
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2009, 17 (02) : 126 - 130
  • [10] CLINICAL-EVALUATION OF NEW CANCER-ASSOCIATED ANTIGEN CA125-II IN EPITHELIAL OVARIAN CANCERS - COMPARISON WITH CA125
    KOBAYASHI, H
    TAMURA, M
    SATOH, T
    TERAO, T
    CLINICAL BIOCHEMISTRY, 1993, 26 (03) : 213 - 219